Publications by authors named "Iratxe Zarragoikoetxea-Jauregui"
Comparative Temporal Analysis of Morbidity and Early Mortality in Heart Transplantation with Extracorporeal Membrane Oxygenation Support: Exploring Trends over Time.
Biomedicines
September 2024
Article Synopsis
- - The study investigates the impacts of using venoarterial extracorporeal membrane oxygenation (VA-ECMO) as a support mechanism for patients undergoing urgent heart transplants over a 17-year period, focusing on morbidity and mortality rates.
- - Results indicate that while the number of patients able to receive transplants without mechanical ventilation has increased, there have been no significant changes in overall mortality rates within 30 days, one year, or five years across different time periods.
- - Comorbidity rates were high, averaging 3.33 per patient, with common complications including vascular issues, the need for post-transplant ECMO, and myopathy, especially more pronounced in recent years.
Usefulness of biomarkers to predict prognosis after heart transplant.
Rev Esp Cardiol (Engl Ed)
December 2024
Introduction And Objectives: Heart transplant (HT) represents a major physiological stress, resulting in elevated levels of analytical biomarkers. This study aimed to determine whether changes in biomarker levels after HT can identify patients with a poor prognosis.
Methods: A prospective longitudinal noninterventional study was conducted in 149 consecutive patients undergoing HT from July 2017 to July 2023.
Background: The purpose of the study was to analyze postcardiac transplant complications in patients who received transplants with short-term mechanical ventricular assist devices and to compare complications according to the type of device.
Methods: Ambispective and consecutive study of urgent heart transplants from 2015 to 2019. Pediatric transplants, retransplants, and combined transplants were excluded.
Background: The purpose of this study was to compare early and late survival among patients who have undergone heart transplantation (HTx) with a short-term mechanical assist device.
Methods: This was an ambispective, single-center, consecutive study of patients undergoing urgent HTx for 5 years. Pediatric transplants, retransplants, and combined transplants were excluded.
Objective: To determine micafungin plasma levels and pharmacokinetic behavior in patients treated with extracorporeal membrane oxygenation.
Methods: The samples were taken through an access point before and after the membrane in two tertiary hospitals in Spain. The times for the calculation of pharmacokinetic curves were before the administration of the drug and 1, 3, 5, 8, 18 and 24 hours after the beginning of the infusion on days one and four.